Difference between revisions of "WSI21-23-Case-2"
From MGH Learn Pathology
(Automatic edit to upgrade to new templates) |
(Added status template) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 17: | Line 17: | ||
Metastatic kinase fusion-related thyroid carcinoma (0.6 cm, in aggregate). | Metastatic kinase fusion-related thyroid carcinoma (0.6 cm, in aggregate). | ||
|reasonCode=Not provided. | |reasonCode=Not provided. | ||
| − | |subject= | + | |subject=MGH |
| − | |performer= | + | |performer=PMS36 |
|authoredOn=February 11, 2021 03:17:13 PM | |authoredOn=February 11, 2021 03:17:13 PM | ||
|requester=Aja51 | |requester=Aja51 | ||
|sequence=2 | |sequence=2 | ||
| + | |access=public | ||
}} | }} | ||
{{Media | {{Media | ||
| Line 74: | Line 75: | ||
|subject=Z0FBQUFBQmdKVXM2dUhfaVdEQ2ducEE1Q194SkJqVWxoSGZQX0gxQ24zQzMtRWN4ZjVVMl9tbzFNRkk4OHY2eGJsN19TMmNxemJXUG1GNXNIZzN0UnFLaE9qZTd5V3RTdm5XNWRwRDN3bVVIWjRBVk1JYmpuRWM9 | |subject=Z0FBQUFBQmdKVXM2dUhfaVdEQ2ducEE1Q194SkJqVWxoSGZQX0gxQ24zQzMtRWN4ZjVVMl9tbzFNRkk4OHY2eGJsN19TMmNxemJXUG1GNXNIZzN0UnFLaE9qZTd5V3RTdm5XNWRwRDN3bVVIWjRBVk1JYmpuRWM9 | ||
|modality=mrxs | |modality=mrxs | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Aja51 | ||
| + | |authoredOn=February 11, 2021 03:17:13 PM | ||
}} | }} | ||
Latest revision as of 14:14, December 9, 2024
